Criticare Systems Announces Introduction of New Products.

MILWAUKEE--(BUSINESS WIRE)--March 24, 1999--Criticare Systems, Inc. (NASDAQ-NMS:CXIM) announced today the worldwide release of three next generation products.

The second generation 2.4 GHz Multiple Parameter Telemetry (MPT(TM)) System offers a patented two-way communication system providing monitoring and paging on a single antenna structure within a hospital. This effectively reduces costs, simplifies installation, and improves operating efficiency. Beta site evaluations have resulted in enthusiastic acceptance of this new technology platform.

Criticare's next generation 504DX digital pulse oximeter incorporates the company's proprietary DOX(TM) digital pulse oximetry technology. It was developed to address the needs of both hospital and alternate care markets worldwide. Early product trials have prompted high marks for its performance, compact size, and portability.

The compact 507NJC Handheld Blood Pressure Monitor is also targeted for worldwide hospital and alternate care markets. This product is the second in a family of miniaturized handheld monitors that Criticare continues to develop. It will be actively promoted to direct as well as OEM customers, an area in which the company is aggressively expanding its focus.

Emil Soika, Criticare CEO, said, "We are excited about these three product releases. They represent the first output of an aggressive development program designed to provide a wider range of products for hospital and alternate site markets. It is Criticare's ongoing initiative to provide its customers with products based on advanced technologies to help them reduce costs and enhance patient monitoring. We believe these products will expand our global market presence and increase shareholder value."

Criticare Systems, Inc., designs, manufactures and markets cost-effective patient monitoring systems and noninvasive sensors for a wide range of hospitals and alternate health care environments throughout the world.

This press release contains forward-looking statements. Such statements refer to the company's beliefs and expectations. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described. Such uncertainties include, but are not limited to, the market acceptance of the new products, the actual performance of the products in a variety of customer settings, the risk of new and better technologies, as well as general conditions in the company's markets.